Form 4 for WLK WESTLAKE CORP
Accepted 2022-03-24 00:00:00 ET · period of report 2022-03-23 · accession 0001567619-22-007422 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-03-24 | 2021-03-23+ | WLK | Bender Mark Steven | EVP, CFO | M - OptEx | $72.82 | +6,000 | 33.7K | +22% | +$436.9K |
| DM | 2022-03-24 | 2022-03-23 | WLK | Bender Mark Steven | EVP, CFO | S - Sale+OE | $125.17 | -6,000 | 30.7K | -16% | -$751.0K |
| DM | 2022-03-24 | 2022-03-23 | WLK | Bender Mark Steven | EVP, CFO | M - OptEx | $0.00 | -6,000 | 17.0K | -26% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-23 | M | A | 3,000 | $65.81 | 36,725 | D | — | — | |
| 2 | Common | Common Stock | 2021-03-23 | M | A | 3,000 | $79.83 | 33,725 | D | — | — | |
| 3 | Common | Common Stock | 2022-03-23 | S | D | 5,656 | $125.14 | 31,069 | D | — | — | (F1) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $124.618 to $125.49, inclusive. The reporting person undertakes to provide to Westlake Chemical Corp., any security holder of Westlake Chemical Corp. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. |
| 4 | Common | Common Stock | 2022-03-23 | S | D | 344 | $125.69 | 30,725 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $125.66 to $125.69, inclusive. The reporting person undertakes to provide to Westlake Chemical Corp., any security holder of Westlake Chemical Corp. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. |
| 5 | Derivative | Employee Option (right to buy) | 2022-03-23 | M | D | 3,000 | $0.00 | 15,061 | D | $79.83 · — to 2029-02-15 | 3,000 Common Stock | (F3) The stock options are excercisable in three installments of 33%, 33% and 34% on February 15, 2020, 2021 and 2022. |
| 6 | Derivative | Employee Option (right to buy) | 2022-03-23 | M | D | 3,000 | $0.00 | 16,960 | D | $65.81 · — to 2030-02-14 | 3,000 Common Stock | (F4) The stock options are excercisable in three installments of 33%, 33% and 34% on February 14, 2021, 2022 and 2023. |